In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins
- 1 February 1992
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 60 (2) , 596-601
- https://doi.org/10.1128/iai.60.2.596-601.1992
Abstract
A chromogenic Limulus amebocyte lysate assay was used to measure the recovery of 1 endotoxin unit of endotoxin per ml. Purified human high-density lipoprotein, low-density lipoprotein, and apolipoprotein A1 (apo A1) at a maximum concentration of 1 g of protein per liter reduced the recovery to less than 40% of baseline in a both dose- and time-dependent manner and in the absence of other serum components. Furthermore, the lapine fever response to a dose of 1 ml of 5-ng/ml endotoxin per kg was reduced by greater than 0.5 degrees C (P less than 0.005) when the solution was preincubated in vitro with 0.5 g of apo A1 per liter. By the Limulus test, a maximum concentration of 0.01 g of apolipoprotein B (apo B) per liter (which contained deoxycholate, a known endotoxin-disaggregating agent) reduced recovery to 0% in a dose- but not time-dependent manner. In heat-inactivated (56 degrees C, 1 h) normal human serum, high-density lipoprotein cholesterol (P less than 0.005) and apo A1 (P less than 0.05) correlated inversely with endotoxin recovery, but, paradoxically, apo B correlated directly with endotoxin recovery (P less than 0.05), while low-density lipoprotein cholesterol showed no significant correlation. INTRALIPID alone had no effect on endotoxin recovery. Addition of a maximum of 10 g of INTRALIPID per liter to 0.0042 g of apo B per liter increased endotoxin recovery from approximately 30 to 80% (P less than 0.001), but addition of INTRALIPID to 0.25 g of apo A1 per liter decreased recovery from approximately 30 to 20% (P less than 0.001). We conclude that (i) lipoproteins are endotoxin inactivators; (ii) this ability of lipoproteins may be modulated by their lipid component (lipid-endotoxin interaction); (iii) apo A1 is capable of directly inactivating endotoxin (protein-endotoxin interaction).Keywords
This publication has 20 references indexed in Scilit:
- Correlation between endotoxin‐neutralizing capacity of human plasma as tested by the limulus‐amebocyte‐lysate‐test and plasma protein levelsFEBS Letters, 1990
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990
- Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.Journal of Clinical Investigation, 1990
- Neutralization and Lipoprotein Binding of Lipopolysaccharides in Tolerant Rabbit SerumThe Journal of Infectious Diseases, 1986
- Biological Activity, Lipoprotein-binding Behavior, and In Vivo Disposition of Extracted and Native Forms of Salmonella typhimurium LipopolysaccharidesJournal of Clinical Investigation, 1982
- Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.Journal of Clinical Investigation, 1981
- Properties of Reference Escherichia coli Endotoxin and Its Phthalylated Derivative in HumansThe Journal of Infectious Diseases, 1981
- New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma.Journal of Clinical Investigation, 1981
- New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.Journal of Clinical Investigation, 1979
- An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediationJournal of Clinical Investigation, 1972